CVS Health (CVS) to Release Quarterly Earnings on Wednesday

CVS Health (NYSE:CVS) will likely be announcing its Q3 2025 results before the market opens on Wednesday, October 29th. Analysts expect the company to announce earnings of $1.36 per share and revenue of $98.8459 billion for the quarter. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS.Interested persons can find conference call details on the company’s upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Wednesday, October 29, 2025 at 8:00 AM ET.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, topping the consensus estimate of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm had revenue of $98.92 billion for the quarter, compared to analysts’ expectations of $94.87 billion. During the same period in the previous year, the business earned $1.83 earnings per share. CVS Health’s revenue for the quarter was up 8.4% compared to the same quarter last year. On average, analysts expect CVS Health to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

CVS Health Price Performance

Shares of CVS Health stock opened at $82.44 on Tuesday. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74. The company’s 50-day moving average price is $75.82 and its two-hundred day moving average price is $68.75. CVS Health has a 52 week low of $43.56 and a 52 week high of $83.52. The stock has a market cap of $104.56 billion, a PE ratio of 23.03, a price-to-earnings-growth ratio of 0.90 and a beta of 0.60.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd will be given a $0.665 dividend. The ex-dividend date is Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.2%. CVS Health’s payout ratio is 74.30%.

Analyst Upgrades and Downgrades

Several brokerages have commented on CVS. Baird R W upgraded shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 14th. Wolfe Research raised their price objective on CVS Health from $80.00 to $85.00 and gave the stock an “outperform” rating in a research note on Monday, September 22nd. Jefferies Financial Group raised their price objective on CVS Health from $80.00 to $92.00 in a research note on Wednesday, October 15th. Barclays raised their price objective on CVS Health from $80.00 to $87.00 and gave the stock an “overweight” rating in a research note on Thursday, September 4th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of CVS Health in a research note on Tuesday, October 14th. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $83.38.

Insider Activity

In other news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director owned 22,156 shares in the company, valued at $1,573,519.12. This represents a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.22% of the stock is owned by insiders.

Institutional Trading of CVS Health

A number of hedge funds have recently modified their holdings of CVS. Canada Pension Plan Investment Board lifted its holdings in shares of CVS Health by 67.9% in the second quarter. Canada Pension Plan Investment Board now owns 1,541,842 shares of the pharmacy operator’s stock valued at $106,356,000 after purchasing an additional 623,715 shares in the last quarter. Adage Capital Partners GP L.L.C. raised its holdings in shares of CVS Health by 43.2% during the second quarter. Adage Capital Partners GP L.L.C. now owns 1,609,599 shares of the pharmacy operator’s stock worth $111,030,000 after acquiring an additional 485,825 shares in the last quarter. Ameriprise Financial Inc. boosted its position in CVS Health by 5.2% during the second quarter. Ameriprise Financial Inc. now owns 7,855,845 shares of the pharmacy operator’s stock valued at $541,903,000 after purchasing an additional 385,806 shares during the last quarter. Sei Investments Co. boosted its position in CVS Health by 17.4% during the second quarter. Sei Investments Co. now owns 905,715 shares of the pharmacy operator’s stock valued at $62,474,000 after purchasing an additional 134,535 shares during the last quarter. Finally, Raymond James Financial Inc. boosted its position in CVS Health by 4.4% during the second quarter. Raymond James Financial Inc. now owns 3,191,584 shares of the pharmacy operator’s stock valued at $220,155,000 after purchasing an additional 133,875 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.